Yog tias koj puas tau xav paub vim li cas qee tus dev teb txawv rau cov tshuaj tiv thaiv kab mob ntau dua li lwm tus, cov tshuaj feem ntau yog ib hom - MDR1. Qhov kev sib raug zoo no tseem ceeb rau cov kws tshawb fawb, kws kho tsiaj thiab cov kws kho tsiaj uas cuam tshuam nrogmilbemycin oxime hmoov txhua hnub. Hauv tsab ntawv no peb rhuav tshem cov kev tshawb fawb thiab txhais ua lus Askiv yooj yim los piav qhia vim li cas qhov kev kawm no tseem ceeb heev hauv kev saib xyuas tsiaj tam sim no.

Milbemycin Oxime hmoov
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
(2) Cov ntsiav tshuaj
Rau dev: 2.3mg / 5.75mg / 11.5mg / 23.0mg
Rau miv: 5.75mg / 11.5mg / 23.0mg
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Internal Code: BM-1-112
Milbemycin Oxime CAS 129496-10-2
Lub khw tseem ceeb: Tebchaws Asmeskas, Australia, Brazil, Nyiv, Lub Tebchaws Yelemees, Indonesia, UK, New Zealand, Canada thiab lwm yam.
MDR1 cuam tshuam li cas rau kev siv Milbemycin Oxime Powder hauv Cov dev rhiab heev?
MDR1 Gene yog dab tsi thiab Vim Li Cas Nws Tseem Ceeb?
MDR1 tam sim no paub zoo dua li ABCB1 thiab cov lej rau cov protein P-glycoprotein (P-gp). Cov protein no ua haujlwm raws li tus neeg saib xyuas molecular ntawm cov hlab ntsha-hlwb barrier, nquag thauj qee cov tshuaj tawm ntawm lub hauv paus paj hlwb ua ntej lawv mus txog qib txaus ntshai. Cov dev uas muaj kev hloov pauv hauv cov noob no feem ntau hu ua MDR1 (-/-) thiab muaj lub twj tso kua mis P-gp uas tsis ua haujlwm. Nws tuaj yeem tso cai rau cov tshuaj uas ib txwm tsis tuaj yeem dhau los ntawm cov ntshav-hlwb thaiv kev nkag mus rau hauv thiab sib sau ua rau tuag taus.
Koj yuav pom qhov kev hloov pauv no ntawm tus nqi siab heev nyob rau hauv Collie, Sheltie, Aussie thiab ntau lwm yam tsiaj uas muaj feem cuam tshuam.


Kev tshawb fawb luam tawm nyob rau hauv phau ntawv Journal of Veterinary Pharmacology thiab Therapeutics pom tias txog li 35% ntawm North American Rough Collies muaj qhov hloov pauv MDR1. Qhov no tsis yog ib qho piv txwv, tab sis ib qho kev muaj txiaj ntsig zoo nrog kev cuam tshuam ncaj qha rau kev xaiv thiab koob tshuaj tiv thaiv kab mob.
Vim li cas Milbemycin Oxime Powder muab txoj hauv kev nyab xeeb rau cov dev no
Milbemycin oxime hmoov, txawm li cas los xij, tsis zoo li ntau lwm cov macrocyclic lactones ntawm no. Raws li nws cov tshuaj pharmacokinetic profile thiab molecular molecular molecular, milbemycin oxime tsis tshua muaj peev xwm hla cov ntshav-hlwb barrier dua ivermectin.
Cov dev (xws li MDR1 rhiab heev canines) noj ntawm 3 mg / kg lub cev hnyav / hnub tsis tu ncua hauv kev sim tshuaj toxicity ntev tsis tau tsim teeb meem neurological.Qhov kev nyab xeeb no ua rau milbemycin oxime cov tshuaj xaiv rau cov kws tshawb fawb kuaj cov tshuaj tiv thaiv kab mob hauv cov noob caj noob ces. Nws yog qhov kev xaiv ntawm tus kws tshawb fawb kws kho tsiaj, tswj kev ua haujlwm dav dav yam tsis muaj kev pheej hmoo neurotoxic profile uas cuam tshuam kev tshawb nrhiav nrog lwm cov macrolides.
Milbemycin Oxime Powder Mechanism: Nkag siab Nws Kev Sib Raug Zoo Nrog Parasite Ion Channels
Glutamate-Gated Chloride Channels raws li lub hom phiaj tseem ceeb
Kev ua haujlwm antiparasitic ntawmMilbemycin Oxime hmoovyog kho los ntawm kev nyiam khi rau glutamate-gated chloride ion channels (GluCl channels) ntawm cov paj hlwb thiab cov leeg hlwb ntawm invertebrates. Cov kab no muaj nyob rau hauv nematodes thiab arthropods tab sis tsis nyob hauv cov tsiaj vertebrate. Milbemycin oxime khi rau cov channel no thiab tsis tso cai rau lawv kaw. Qhov no induces nruam influx ntawm chloride ions los ntawm lub hlwb ntawm cov cab.
Qhov no hyperpolarisation nres ib txwm neuromuscular kev sib txuas, ua rau tuag tes tuag taw thiab tuag ntawm cov cab. Ob tus neeg laus kab mob thiab theem plaub larval theem (L4) yog raug,


zoo heev nce qhov kho qhov rais piv rau cov kev kho mob uas tsuas yog cov neeg laus cov kab mob. Cov kev tshawb fawb Parasitological tau pom tias muaj txiaj ntsig tiv thaiv kab mob plawv (Dirofilaria immitis), hookworms (Ancylostoma caninum), roundworms (Toxocara canis) thiab whipworms (Trichuris vulpis).
Yog vim li cas Mammals thiaj tsis cuam tshuam
Ib feem tseem ceeb ntawm milbemycin oxime txoj kev nyab xeeb yog qhov ze ntawm qhov tsis muaj GluCl hauv cov kab mob hauv lub hlwb. Cov tsiaj nyeg muaj GABA-gated chloride raws uas yog rau kev ua haujlwm zoo sib xws tab sis muaj qhov sib txuas qis dua rau milbemycin oxime ntawm cov tshuaj kho mob.
Qhov no muaj lub qhov rais xaiv qhov tseem ceeb uas cov tshuaj cuam tshuam nrog parasite physiology ntawm ntau npaum li cas uas tsis tshua muaj txiaj ntsig ntawm tus tswv tsev biology.Qhov kev tshawb pom no tseem ceeb tshwj xeeb hauv cov dev nrog MDR1 kev hloov pauv. Txawm hais tias thaum P-gp kev ua haujlwm raug txo qis thiab, muaj peev xwm, muaj kev nce ntxiv hauv cov tshuaj nkag mus rau hauv CNS, qhov kev puas tsuaj raug txwv los ntawm qhov tsis muaj qhov sib txuas siab hauv cov ntaub so ntswg ntawm lub hlwb. Cov yam ntxwv zoo li no yog qhov laj thawj loj vim li cas cov kws tshawb fawb xaiv siv milbemycin oxime hmoov thaum ua kev sim nrog cov tsiaj rhiab.
MDR1 thiab Milbemycin Oxime Powder: Tshawb nrhiav tshuaj rhiab heev sib txawv ntawm cov dev
Sib piv Genetic Risk Profiles hla cov noob
The mutation occurs at differing frequencies in different dog breeds and the variations in medicine sensitivity are significant and need to be considered by researchers. In some breeds, as the Border Collie or McNab Shepherd, the prevalence may be >40%. Cov dev sib xyaw ua ke muaj qhov tshwm sim tsawg dua, tab sis tsis yog xoom. Genotyping ua ntej cov tshuaj tiv thaiv kab mob tau dhau los ua qhov pom tseeb dua rau cov chaw tshawb fawb raug cai.
Yog li, milbemycin oxime muaj kev nyab xeeb heev hauv MDR1 cov tsiaj cuam tshuam, tab sis qhov no tsis txhais tau tias tsis muaj kev phom sij ntawm ib koob, tab sis qhov ntsuas kev kho mob tseem ua tau.


Cov kws tshawb fawb kawm txog kev tshem tawm cov kab mob parasites hauv cov neeg raug tsim txom yuav tuaj yeem ua qhov kev ntsuam xyuas tshuaj tiv thaiv kab mob ntau dua, tsis muaj kev cuam tshuam tsis zoo ntawm cov tsiaj tshwj xeeb neurotoxicity.
Qhov cuam tshuam rau Formulation Research thiab Product Development
MDR1 kev hloov pauv muaj qhov cuam tshuam ncaj qha rau kev txhais cov ntaub ntawv ua tau zoo thiab kev nyab xeeb rau cov neeg tsim khoom ntawm cov tshuaj tiv thaiv kab mob tshiab. Cov tshuaj uas ua haujlwm hauv ib pab pawg tsiaj qus tuaj yeem coj txawv me ntsis hauv MDR1-mutant cohort. Milbemycin oxime hmoov muab qhov kev sim ua kom zoo sib xws raws li nws tsis tshua muaj peev xwm hla cov tsiaj nyeg CNS txawm tias P-gp kev ua haujlwm tsis zoo.
Yuav Ua Li Cas Milbemycin Oxime Powder Txhawb Kev Tiv Thaiv Kab Mob Hauv Cov Tsiaj Tshwj Xeeb
Precision Dosing rau Cov Hluas, Cov Laus, thiab Tsiaj Tsiaj
Ib tug tswv yim zoo ntawmmilbemycin oxime hmoovyog qhov tseeb heev tuning ntawm cov tshuaj tau. Nws yuav raug ntsuas rau qib 0.1 mg / kg rau cov kws tshawb fawb thiab cov kws tsim qauv ua rau nws zoo tagnrho rau cov tsiaj sib txawv ntawm qhov hnyav thiab lub neej. Cov menyuam yaus hnub nyoog qis dua rau lub lis piam, cov dev laus uas muaj qhov txo qis hauv cov kab mob siab thiab cov tsiaj uas muaj teeb meem kev noj qab haus huv yog nyob ntawm cov pab pawg uas qhov tseeb npaum li cas tseem ceeb heev.
Cov txiaj ntsig ntawm Pharmacokinetic qhia tau hais tias kwv yees li 90% ntawm kev noj tshuaj ntawm qhov ncauj ntawm milbemycin oxime raug tshem tawm hauv cov quav raws li cov tshuaj niam txiv tsis hloov pauv hauv 48 teev.


Kev tshem tawm sai sai txo qis cov ntaub so ntswg thauj khoom thiab muaj kev cuam tshuam me ntsis ntawm daim siab enzymes xws li GOT thiab GPT uas ua rau nws tsim nyog rau kev kho mob mus sij hawm ntev hauv cov tsiaj uas lub siab ua haujlwm yuav muaj teeb meem.
Multi-Species thiab Multi-Parasite Scenarios
Qhov muaj peev xwm ntawm cov kab mob kis tau los ntawm cov tsiaj hauv tsev nrog ntau tus tsiaj lossis cov chaw tshawb fawb uas ua rau dev thiab miv ua ke ua rau muaj kev tiv thaiv kab mob. Milbemycin oxime nce mus txog qib siab tshaj plaws hauv cov ntaub so ntswg adipose 4-8 teev tom qab noj tshuaj hauv qhov ncauj, muab lub qhov rais txuas ntxiv ntawm kev ua ub no thoob plaws hauv lub voj voog kev loj hlob ntawm cov kab mob ectoparasites.
Nws kuj tseem ua ke nrog praziquantel, yog li koj tuaj yeem kho koj cov kab mob npaws thiab kab kab mob ib txhij hauv tsawg zaus.
Milbemycin Oxime Powder Daim Ntawv Thov hauv Kev Tiv Thaiv Kab Mob Tus Kheej thiab Kev Tswj Xyuas Tsiaj
Tsim Daim Ntawv Qhia Tiv Thaiv Ib puag ncig MDR1 xwm txheej
The widespread inclusion of MDR1 genotyping in a science-based preventative plan is now a standard step. Knowing the dog's genetic state enables formulators and veterinaries to be more confident when choosing milbemycin oxime as the antiparasitic backbone. Monthly oral treatment started around a month before the beginning of the mosquito season has been demonstrated to provide heartworm prevention rates >99%, muab lub qhov rais tiv thaiv kev ntseeg siab uas yog raws li kev sib kis kab mob ntawm cov kab mob parasite.
Layered tiv thaiv los ntawm qhov ncauj milbemycin oxime ua ke nrog cov tshuaj pleev ib ce, coupling nrog cab kab mob tuag nrog rau sab nrauv vector cuam tshuam.

Qhov no ob-txoj kev mus kom ze tau dhau los ua ntau dua thiab lees paub tias yog txoj hauv kev ua tiav tshaj plaws muaj rau cov tsiaj nyob hauv cov xwm txheej siab.

Los ntawm Stray Rehabilitation mus rau Long-Term Health Management
Cov strays tshiab feem ntau muaj ntau yam kab mob sib kis nyob rau tib lub sijhawm, suav nrog cov kab mob sib kis, kab mob hookworms thiab kab mob dev mub. Milbemycin oxime muaj qhov dav spectrum profile uas ua rau muaj ntau lub nra hnyav rau kev tawm tsam ib txhij nrog kev sib koom ua ke, txo lub sijhawm ntawm kev sib cais thiab kev soj ntsuam ua ntej tus tsiaj tshiab koom nrog tsev neeg. Hauv kev xyaum kho mob, kev tswj hwm txhua hli tau pom tias txo qis cov kab mob cab hauv tsev los ntawm ntau npaum li 92%, tus lej uas hnyav hnyav ob qho tib si hauv cov ntaub ntawv kawm thiab hauv kev sib txuas lus cov khoom siv tau zoo.
Xaus
MDR1 tsis yog qee qhov teeb meem esoteric ntawm kev tshawb fawb antiparasitic; nws yog lub fulcrum nyob ib ncig ntawm cov tshuaj muaj kev nyab xeeb, yug me nyuam rhiab heev thiab kev kho mob zoo pivot.Milbemycin Oxime hmoovNws yog ib qho tshwj xeeb hauv ib puag ncig no vim nws cov tshuaj pharmacological tau sib xws nrog MDR1 sib txawv yam tsis muaj kev cuam tshuam dav dav ntawm cov tshuaj tiv thaiv kab mob. Nws lub hom phiaj ion channel tshwj xeeb, ceev ceev tshem tawm kinetics, thiab ua pov thawj kam rau hauv cov kab mob genetic susceptible breeds, ua rau nws txoj kev xaiv suab rau cov kws tshawb fawb, cov tsim qauv thiab cov khoom tsim tawm hauv veterinary parasitology.
FAQ
Q1: Puas yog milbemycin oxime hmoov zoo rau Collie yug me nyuam nrog MDR1 kev hloov?
+
-
Yog lawm. Milbemycin oxime nthuav tawm qhov nkag mus ntawm cov ntshav-hlwb tsis zoo dua li lwm cov macrocyclic lactones. Qhov tseeb, qhov kev kuaj mob toxicity ntev qhia tau hais tias txawm tias nyob rau ntau npaum li cas, cov teeb meem neurological tsis tau pom nyob rau hauv cov tsiaj rhiab thiab nws yog ib qho ntawm cov kev nyab xeeb tshaj plaws rau cov dev nrog MDR1 (- / -) genotype.
Q2: Cov kab mob dab tsi ua rau milbemycin oxime hmoov lub hom phiaj?
+
-
Milbemycin oxime muaj txiaj ntsig zoo tiv thaiv kab mob sab hauv thiab sab nrauv. Cov no muaj xws li cov kab mob plawv ( Dirofilaria immitis ), cov kab mob hauv plab (mob plab, cov kab mob hookworms, thiab whipworms ), thiab ntau hom mites ( Demodex canis thiab Sarcoptes scabiei ). Cov tshuaj kho mob muaj zog tiv thaiv ob leeg larvae thiab cov laus nematodes.
Q3: Vim li cas MDR1 muaj feem cuam tshuam thaum xaiv cov tshuaj tiv thaiv kab mob rau kev tshawb fawb?
+
-
Cov dev nrog MDR1 kev hloov pauv tsis muaj lub twj tso kua mis P-glycoprotein ua haujlwm. Qhov no ua rau qee cov tshuaj tsim nyob rau hauv lub hauv paus paj hlwb mus rau theem txaus ntshai. Los ntawm kev xaiv cov tshuaj xws li milbemycin oxime uas muaj tsawg dua CNS nkag mus thiab dav dua, koj txwv qhov kev pheej hmoo ntawm kev muaj kab mob tshwj xeeb thiab ua kom pom tseeb qhov kev sim pom thoob plaws cov neeg tshawb fawb sib txawv.
Koom Tes Nrog Bloomtechz rau Kev Txhim Kho Milbemycin Oxime Powder Supply
Ntawm Bloomtechz, peb nkag siab tias kev tshawb fawb nruj thiab kev tsim khoom xav tau amilbemycin oxime hmoovtus neeg muag khoom koj tuaj yeem ntseeg tau tag nrho. Peb lub chaw tsim khoom tau lees paub GMP hauv Xi'an tuav cov ntawv pov thawj los ntawm US-FDA, EU-GMP, PMDA, thiab CFDA, ua kom txhua pawg ua tau raws li cov qauv zoo tshaj plaws thoob ntiaj teb. Peb muab cov hmoov API ntshiab, meej meej ntawm HPLC, LC-MS, thiab HNMR tsom xam, nrog rau kev tsim kho kev txhawb nqa los ntawm OEM / ODM cov kev pabcuam. Peb cov txheej txheem kev ruaj ntseg triple-link zoo - kev tshuaj xyuas lub Hoobkas, kev tshuaj xyuas hauv tsev QA / QC, thiab kev pov thawj thib peb - txhais tau tias koj tau txais kev coj dawb huv zoo ib yam thiab cov ntaub ntawv ntawm txhua qhov kev txiav txim. Txawm hais tias koj xav tau cov kev tshawb fawb me me lossis kev tsim khoom loj-up, peb pab pawg R & D muab kev txhawb nqa tag nrho los ntawm kev nug txog kev xa khoom. Mus txog hnub no thiab nrhiav pom yog vim li cas tshaj 24 lub koom haum thoob ntiaj teb tso siab rau Bloomtechz ua lawv tus khub tshuaj lom neeg nyiam.
📧 Hu rau peb ncaj qha:Sales@bloomtechz.com
Cov ntaub ntawv
1. Mealey, KL, Bentjen, SA, Gay, JM, & Cantor, GH (2001). Ivermectin rhiab heev nyob rau hauv collies yog txuam nrog ib tug deletion mutation ntawm mdr1 noob. Pharmacogenetics, 11(8), 727–733.
2. Tranquilli, WJ, Paul, AJ, Seward, RL, Todd, KS, & Dipietro, JA (1987). Teb rau physostigmine kev tswj hwm hauv cov dev collie nthuav tawm ivermectin toxicosis. Phau ntawv Journal of Veterinary Pharmacology thiab Therapeutics, 10(1), 96–100.
3. Wolstenholme, AJ, & Rogers, AT (2005). Glutamate-gated chloride channels thiab hom kev ua ntawm avermectin / milbemycin anthelmintics. Parasitology, 131 (Suppl), S85–S95.
4. Paul, AJ, Tranquilli, WJ, & Hutchens, DE (1987). Kev soj ntsuam soj ntsuam hauv cov kab mob sib kis tau muab milbemycin oxime qhov ncauj. American Journal of Veterinary Research, 48(4), 684–685.
5. Geyer, J., Döring, B., Godoy, JR, Moritz, A., & Petzinger, E. (2005). Kev txhim kho ntawm kev tshuaj ntsuam gene tshiab rau kev kuaj pom kev ua haujlwm ntawm P-glycoprotein hauv cov dev nrog MDR1 kev hloov pauv. Phau ntawv Journal of Veterinary Pharmacology thiab Therapeutics, 28(5), 455–460.
6. Doherty, TJ, Ballard, JB, & Brown, SA (1994). Pharmacokinetics ntawm milbemycin oxime hauv cov dev tom qab kev tswj hwm qhov ncauj. Phau ntawv Journal of Veterinary Pharmacology thiab Therapeutics, 17(5), 335–339.

